News and Comments

Biotechnology Companies: A Model that’s Gaining Visibility

  Tuesday, December 07, 2010

The biotechnology company model founded on management skills rather than purely on scientific skills has begun to gain investors’ appreciation. The reason is that many firms built around skilled, experienced entrepreneurs have succeeded in bringing a large number of drugs to the market and in marketing them competently. These firms license or acquire drugs in mid-or late-phase trials. They sometimes acquire therapeutic molecules in early-stage development only if these molecules prove to have optimal affinity on validated proteins in pathways of diseases, and produce desired agonist or antagonist effects. In order to select the products that can be called breakthroughs, the most successful of the firms established and run by entrepreneurs with strong business acumen employ specialists in pharmaceutical sciences and in clinical trials. These scientists have experience in sensitive areas such as drug development, clinical trials, medicinal chemistry, and other important disciplines required for drug discovery, development and testing.   More...

Recent Postings



PTC Therapeutics (PTCT) Intermune (ITMN) Aimmune Therapeutics (AIMT) Trastuzumab-DM1 Revlimid (lenolidamide) Micromet (MITI) Alnylam (ALNY) Auspex (ASPX) Dynavax (DVAX) Theravance (THRX) Vertex (VRTX) REGULUS (RGLS) Biocryst (BCRX) Elan (ELN) ARCA (ABIO) Alder Biopharmaceuticals (ALDR) Velcade (bortezomib) NEKTAR (NKTR)) Idenix (IDIX) Anacor (ANAC) Agenus (AGEN) Pluristem (PSTI) INNOVIVA (INVA) Anadys (ANDS) Roche (RHHBY) Dendreon (DNDN) Amgen (AMGN) VANDA (VNDA) Sequenom (SQNM) Global Cell Therapeutics (GBT) Gilead (GILD) Benlysta (belimumab) Herceptin BIOMARIN (BMRN) ISIS (ISIS) AGOS (ARGS) Intrexon (XON) TOKAI (TKAOI) Zerenex Biogen Idec (BIIB) Agenus (AGEN ACADIA (ACAD) GlaxoSmithKline (GSK) IDERA (IDRA) Seattle Genetics (SGEN) ImmunoGen (IMGN) CompuGen (CGEN) KERYX (KERX) OSI (OSIP) ADVENTRIX (ANX) Editas (EDIT) HALOZYME (HALO) Illumina (ILMN) ABBVIE (ABBV) Merck (MRK) Prolor Biotech (PBTH) Bristol-Myers Squibb (BMY) Inovio (INO) Roche (ROCHE) MODERNA Onyx (ONXX) Jazz Pharmaceuticals (JAZZ) Sanofi (SNA) Galena (GALE) Sangamo (SGMO) JUNO (JUNO) ARGOS (ARGS) Prosensa (RNA) Theravance Bio Pharma (TBPH) KITE (KITE) Telaprevir Incyte (INCY) Abbott Laboratories (ABT) Endometrial Cancer C4 Therapeutics Rapamune Ariad (ARIA) ZALTRAP™ Ziofpharm (ZIOP) Sarepta (SRPT) Mirati Therapeutics (MRTX) Sanofi (SNY) Valeant Pharmaceuticals International (VRX) Regeneron (REGN) Tysabri Multiple Myeloma RenenxBio (RGNX) NANTKWEST (NK) galapagos (GLPG) Spike Therapeutics (ONCE) Human Genome Sciences (HGSI) AstraZeneca (AZN) Cytokinetics (CYTK) Vitae Pharmaceuticals (VTAE) GUARDIAN HEALTH SYNTA (SNTA) Human Longevity (HLI) SUNESIS PHARMACEUTICALS (SNSS) Exelixis (EXEL) Genentech Ionis (IONS) Array Pharmaceuticals (ARRY) Intercept (ICPT) NOVOCURE (NVCR) AERIE PHARMACEUTICALS Xoma (XOMA) Sanofi-Aventis (SAN) Ridaforolimus SERES THERAPEUTICS (MCRB)